Isla Health expands to the Caribbean with transformative Trinidad & Tobago partnership
UK-based health tech company Isla Health has successfully launched its first Caribbean initiative. Following a transformative six-month digital health pilot at Sangre Grande Hospital in Trinidad & Tobago, the Eastern Regional Health Authority (EHRA) has decided to roll out Isla across all services under a long-term deployment contract. The partnership with the ERHA has already delivered impressive results, including zero surgical site infection readmissions and a two-thirds reduction in wound care visits.
Patients at Sangre Grande benefited from Isla’s Digital Pathway Platform (DPP), which enables remote monitoring through secure image submissions and clinical questionnaires. This innovation is reshaping care delivery for rural communities, allowing patients to receive high-quality treatment from home.
A new model for remote care
Clinical teams at Sangre Grande used Isla’s platform across wound care, surgical wards, and dietetics, resulting in:
- Clinical time savings of 15–30 minutes per patient, plus 30 minutes saved from avoided face-to-face appointments.
- Zero surgical site infection readmissions.
- Wound care visits reduced from 15 to fewer than 5 per day.
“The use of Isla has greatly benefited our patients. We have had zero surgical site infections. This project has been nothing short of amazing.”
Supporting rural communities and national strategy
Patients previously travelling over an hour for care can now receive high-quality treatment from home.
“When patients no longer need to travel over an hour for wound care appointments, and our readmission rates drop to zero, we know we’re making a real difference.”
This initiative aligns with Trinidad & Tobago’s Digital Health Strategy and Roadmap, which aims to improve healthcare quality, efficiency, and equity. Isla’s platform directly addresses key challenges such as capturing patient-submitted data and enabling secure remote care.
Building a new category in healthcare delivery
Isla’s biggest achievement in the UK has been creating and scaling a new category of healthcare solution: the Digital Pathway Platform (DPP).
“Unlike single-point tools, Isla provides the digital foundations for healthcare organisations to design and deploy clinically approved pathways at scale. Real efficiency comes from rethinking care delivery end-to-end, and the DPP enables exactly that.”
Isla now works with over 30 NHS Trusts, powering 200+ pathways across 40+ specialties, with results including:
- Up to 400% ROI reinvested into patient care.
- 87% shorter waiting lists.
- 116,000+ clinical hours released.
The team have shown that it is possible to scale what works. A great example is their collaboration with Guy’s and St Thomas’ NHS Foundation Trust, where Isla powered the largest surgical site infection study ever funded in the UK, benefiting over 20,000 patients.
Another standout is Royal Cornwall Hospitals Trust, which transformed Dermatology and won Health Tech Case Study of the Year 2024/25. Their remote lesion imaging clinics cut face-to-face appointments by 49% and reduced two-week waits from 57 to 12 days.
Patient feedback has been overwhelmingly positive, with 100% of respondents saying they would use the platform again.
“I would like to thank this online project for the service you provide at a very trying time after my surgery. Your kindness, dedication, and healing touch is beyond words.”
Isla Health: Scaling innovation with the NIA
Isla Health has been supported by the NHS Innovation Accelerator (NIA) to help them scale their impact globally.
“The NIA has been instrumental in accelerating Isla’s growth and amplifying our impact. By joining the 2024 cohort, we gained access to invaluable networks of NHS leaders, clinicians, and fellow innovators. This support validated our technology and helped us strengthen adoption across the health service. The credibility of the programme enabled us to showcase results like reducing face-to-face visits by 36%, achieving 75% same-day de-escalations, and delivering 3.8x more clinic capacity. These outcomes opened doors for global partnerships, including our work with ERHA.”
Looking ahead: Global expansion and AI-driven innovation
Isla’s five-year vision is focused on scaling the DPP across the NHS and internationally.
“Our priorities are national scale in the NHS, technology leadership through AI-driven insights and automation, and global expansion. We’re building smarter, faster, more personalised pathways that help clinicians do more with the resources they already have. Our partnership with ERHA is a powerful example of how digital pathways can deliver impact at the population level. By 2030, we aim to be powering digital pathways across multiple countries, with millions of patients benefiting from safer, faster, more efficient care.”
You can view the full news story from Isla Health and find out more about the DDP. You can also connect with Isla Health via their innovation page.
